Clinical Trials in Zhenzhou, China
1 recruiting
Showing 1–9 of 9 trials
Recruiting
A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases
EGFR Mutant Advanced Non-small Cell Lung CancerCentral Nervous System (CNS) Metastases
Alpha Biopharma (Jiangsu) Co., Ltd.800 enrolled34 locationsNCT07143045
Recruiting
Phase 1Phase 2
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
Colorectal, CancerHead and Neck CancerNon-small Cell Lung Cancer+1 more
Betta Pharmaceuticals Co., Ltd.400 enrolled87 locationsNCT04930432
Recruiting
Phase 2
A Study of A166 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer
Her 2 Positive Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.40 enrolled1 locationNCT07299825
Recruiting
Phase 2Phase 3
ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (APEX-03)
Hematologic Malignancies
Beijing InnoCare Pharma Tech Co., Ltd.226 enrolled53 locationsNCT06378138
Recruiting
Phase 1Phase 2
Study of APG2575 Single Agent and Combination Therapy in Patients With Relapsed/Refractory CLL/SLL
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Ascentage Pharma Group Inc.123 enrolled18 locationsNCT04494503
Recruiting
Not Applicable
FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating Hypertension
Hypertension
Shanghai Hongdian Medical CO., LTD180 enrolled27 locationsNCT05590871
Recruiting
Not Applicable
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia
B-ALLB-NHL
Shenzhen Genocury Biotech Co., Ltd.20 enrolled1 locationNCT06678282
Recruiting
Phase 1Phase 2
A Study of LVGN6051 Combined with Anlotinib in Patient with Soft Tissue Sarcoma
Soft Tissue Sarcoma
Lyvgen Biopharma Holdings Limited65 enrolled5 locationsNCT05301764
Recruiting
Phase 4
Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation
Acute B-cell Lymphoblastic Leukemia
Suping ZHANG60 enrolled1 locationNCT06339775